Dendritic cell tumor fusions as a novel tumor vaccine: A phase I trial for patients with metastatic breast cancer.

被引：0
|
作者：
Avigan, D
Gong, JL
Uhl, L
Wu, ZK
Vasir, D
Smith, T
Borges, V
Atkins, M
Stone, C
Giallombardo, N
Schadt, K
Tetreault, JC
Kufe, D
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
45
引用
收藏
页码：14A / 14A
页数：1
相关论文
共 50 条
  • [31] Comparison of estrogen and Progesterone receptor expression on circulating Tumor cells and the Primary tumor in Patients with metastatic Breast cancer.
    Aktas, B.
    Mueller, V.
    Schumacher, K.
    Tewes, M.
    Zeitz, J.
    Kasimir-Bauer, S.
    Rack, B.
    Janni, W.
    Solomayer, E.
    Fehm, T.
    ONKOLOGIE, 2010, 33 : 212 - 212
  • [32] Single Circulating Tumor Cell Detection and Overall Survival in Non Metastatic Breast Cancer.
    Bidard, F-C
    Mathiot, C.
    Mefti, F.
    Delaloge, S.
    Giacchetti, S.
    Salmon, R.
    Mignot, L.
    Sigal-Zafrani, B.
    Vincent-Salomon, A.
    Tembo, O.
    Marty, M.
    Pierga, J-Y
    CANCER RESEARCH, 2009, 69 (24) : 652S - 652S
  • [33] A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
    Chang, Chen-Nen
    Huang, Yin-Cheng
    Yang, Den-Mei
    Kikuta, Kenichiro
    Wei, Kuo-Jen
    Kubota, Toshihiko
    Yang, Wen-Kuang
    JOURNAL OF CLINICAL NEUROSCIENCE, 2011, 18 (08) : 1048 - 1054
  • [34] Anti-tumor effects of dendritic and tumor cell fusions are not dependent on expression of MHC class I and II by dendritic cells
    Takagi, Y
    Kikuchi, T
    Niimura, M
    Ohno, T
    CANCER LETTERS, 2004, 213 (01) : 49 - 55
  • [35] Phase I trial of liposomal doxorubicin and ZD 1839 in patients with refractory gynecological malignancies or metastatic breast cancer.
    Campos, S. M.
    Parker, L.
    Chen, W.
    Bunnell, C. A.
    Atkinson, T.
    Lee, J.
    Matulonis, U. A.
    Harris, L. N.
    Krasner, C. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 276S - 276S
  • [36] A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma.
    Trefzer, U
    Weingart, G
    Adrian, K
    Chen, Y
    Guo, YJ
    Audring, H
    Winter, H
    Walden, P
    Sterry, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 404 - 404
  • [37] Tumor Burden Influences Cytotoxic T Cell Development in Metastatic Breast Cancer Patients-A Phase I/II Study
    Wright, Stephen E.
    Rewers-Felkins, Kathleen A.
    Quinlin, Imelda S.
    Phillips, Catherine A.
    Townsend, Mary
    Philip, Ramila
    Zorsky, Paul
    Klug, Panpit
    Dai, Lijun
    Hussain, Mohammad
    Thomas, Aabu A.
    Sundaramurthy, Chithraleka
    IMMUNOLOGICAL INVESTIGATIONS, 2009, 38 (08) : 820 - 838
  • [38] Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine
    Hardin, Mark O.
    Vreeland, Timothy J.
    Clifton, Guy T.
    Hale, Diane F.
    Herbert, Garth S.
    Greene, Julia M.
    Jackson, Doreen O.
    Berry, John E.
    Nichols, Pauline
    Yin, Sook
    Yu, Xianzhong
    Wagner, Thomas E.
    Peoples, George E.
    IMMUNOTHERAPY, 2018, 10 (05) : 373 - 382
  • [39] A single-center experience with CELLSEARCH system circulating tumor cell test on patients with metastatic breast cancer.
    Montero, Alberto J.
    Eapen, Sara
    Andrews, Ryan M.
    Gorin, Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Allogeneic blood stem cell transplantation for induction of graft versus tumor effect in patients with metastatic breast cancer.
    Ueno, NT
    Rondon, G
    Geisler, D
    Giralt, S
    Mehra, R
    Przepiorka, D
    Andersson, B
    Gajewski, J
    Khouri, I
    Korbling, M
    Seong, D
    Rahman, Z
    vanBesien, K
    Anderlini, P
    Hortobagyi, G
    Champlin, RE
    BLOOD, 1996, 88 (10) : 2440 - 2440
12345